详情页 - 广东省中医院知识库

当前位置：首页 > 详情页

Melatonin Synergizes With Methylprednisolone to Ameliorate Acute Spinal Cord Injury.

13| 认领 | 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

机构： [1]Department of Orthopedic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, [2]Emergency Department, SongBei Hospital of the Fourth Hospital Affiliated with Harbin Medical University, Harbin, China, [3]Postdoctoral Workstation, Harbin Children’s Hospital, Harbin, China, [4]Department of Orthopedics, Bejing Hospital of Traditional Chinese Medicine, Beijing, China, [5]Department of Spine Surgery, Orthopedics Center of Guangdong Provincial People’s Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China, [6]Department of Orthopedic Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China, [7]Department of Orthopedic Surgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China

出处：

DOI：

ISSN：

关键词： melatonin methylprednisolone spinal cord injury factorial design PI3K-AKT1 pathway

摘要：

Methylprednisolone (MP) is the drug of choice for treating spinal cord injury (SCI), but the aggressive dosage regimen used often results in adverse side effects. Therefore, MP should be combined with other drugs to lower the required dose. Melatonin is effective in alleviating nerve damage and inhibiting axonal degeneration. The combination of melatonin and half-dose methylprednisolone (HMP) for spinal cord injury treatment has never been reported. In this study, we established a rat model of T9 spinal cord injury by the Allen's method and assessed the synergistic therapeutic effects of melatonin and HMP by factorial design. Our results demonstrated that melatonin could synergize with HMP to ameliorate acute SCI through PI3K-AKT1 pathway. Combining melatonin with HMP significantly reduced the standard-dose of methylprednisolone and limited its adverse reactions, representing a promising option for treating acute SCI.Copyright © 2022 Bi, Sun, Feng, Shen, Chen, Tan, Li and Lin.

基金：

语种：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2021]版：

大类 | 2 区

医学

小类 | 2 区药学

最新[2025]版：

大类 | 3 区医学

小类 | 3 区药学

JCR分区：

出版当年[2020]版：

Q1 PHARMACOLOGY & PHARMACY

最新[2023]版：

Q1 PHARMACOLOGY & PHARMACY

影响因子： 4.4 最新[2023版] 5 最新五年平均 5.811 出版当年[2020版] 6.006 出版当年五年平均 4.225 出版前一年[2019版] 5.988 出版后一年[2021版]

第一作者：

第一作者机构： [1]Department of Orthopedic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, [2]Emergency Department, SongBei Hospital of the Fourth Hospital Affiliated with Harbin Medical University, Harbin, China, [3]Postdoctoral Workstation, Harbin Children’s Hospital, Harbin, China,

共同第一作者：

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Melatonin Synergizes With Methylprednisolone to Ameliorate Acute Spinal Cord Injury. [2]Role of melatonin in the dynamics of acute spinal cord injury in rats. [3]A progressive compression model of thoracic spinal cord injury in mice: function assessment and pathological changes in spinal cord. [4]Wallerian degeneration assessed by multimodal MRI of cervical spinal cord is associated with neurological impairment after spinal cord injury [5]Multimodal Repair of Spinal Cord Injury With Mesenchymal Stem Cells [6]小檗碱对HepG2胰岛素抵抗细胞PI3K/AKT1/GLUT1信号通路的调控作用 [7]Sodium tanshinone IIA sulfonate promotes spinal cord injury repair by inhibiting blood spinal cord barrier disruption in vitro and in vivo [8]抑制脊髓损伤后疼痛的分子和细胞策略 [9]Polydatin administration attenuates the severe sublesional bone loss in mice with chronic spinal cord injury [10]Transplantation of MiR-28-5p-Modified BMSCs Promotes Functional Recovery After Spinal Cord Injury